Mitochondrial complex II, a novel target for anti-cancer agents

Kluckova, Katarina, Bezawork-Geleta, Ayanachew, Rohlena, Jakub, Dong, Lanfeng, Neuzil, Jiri·2013·Biochimica et Biophysica Acta (BBA) - Bioenergetics
DOI 10.1016/j.bbabio.2012.10.015

Cited by (105)

Items 101–105 of 105

  1. Additional file 1 of Inhibition of ERAD synergizes with FTS to eradicate pancreatic cancer cells
    Du, Rong, Delaney K. Sullivan, Nancy G. Azizian, Liu, Yuanhui, Yulin Li · 2021 · Figshare
  2. Reviewing the thoroughness of human safety testing for succinate dehydrogenase inhibitors: fluopyram as a case study
    Kim Z. Travis, R. Bars, Helen Tinwell · 2026 · Archives of Toxicology
  3. Bioenergetics of lung cancer predicts treatment response and adaptive capacity
    Juan Alberto Pérez-Valencia, Annika Pätzold, Till Plönes · 2026 · Research Square
  4. Hypoxia–ROS–HSP Triad Axis in Cancer: Mechanisms, Crosstalk, and Therapeutic Implications
    Manish Kumar Singh, Hyeong Rok Yun, Jyotsna Suresh Ranbhise, Sunhee Han, Seung Geu Yeo, Fu‐Shi Quan, Bonglee Kim, Sung Soo Kim, Insug Kang · 2026 · Cells
  5. Emerging Anti-cancer Targets in Mitochondria
    Petr Ježek, Katarína Smolková, Aleš Dvořák, Tomáš Olejár · 2014 · Springer eBooks